help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huizenga, N. A. T. M.
Right arrow Articles by Lamberts, S. W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huizenga, N. A. T. M.
Right arrow Articles by Lamberts, S. W. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 3 917-921
Copyright © 1998 by The Endocrine Society


Original Studies

Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus1

Nannette A. T. M. Huizenga, Pieter de Lange, Jan W. Koper, Richard N. Clayton, William E. Farrell, Aart Jan van der Lely, Albert O. Brinkmann, Frank H. de Jong and Steven W. J. Lamberts

Departments of Internal Medicine III (N.A.T.M.H., P.d.L., J.W.K., A.J.v.d.L., F.H.d.J., S.W.J.L.) and Endocrinology and Reproduction (A.O.B.), Erasmus University Rotterdam, 3015 GD Rotterdam, The Netherlands; and the Department of Medicine, Keele University (R.N.C., W.E.F.), Stoke on Trent, ST4 7QB United Kingdom

Address all correspondence and requests for reprints to: Dr. Nannette Huizenga, Dijkzigt University Hospital, Room Bd 277, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

Corticotropinomas are characterized by a relative resistance to the negative feedback action of cortisol on ACTH secretion. In this respect there is a similarity with the clinical syndrome of cortisol resistance. As cortisol resistance can be caused by genetic abnormalities in the glucocorticoid receptor (GR) gene, we investigated whether the insensitivity of corticotropinomas to cortisol is also caused by de novo mutations in the GR gene.

We screened for the GR gene in leukocyte and tumor DNA from 22 patients with Cushing’s disease for mutations using PCR/single strand conformation polymorphism analysis. In a previous study, we identified 5 polymorphisms in the GR gene in a normal population. These polymorphisms were used as markers for the possible occurrence of loss of heterozygosity (LOH) at the GR gene locus.

Except for 1 silent point mutation, we did not identify novel mutations in the GR gene in leukocytes or corticotropinomas from these patients. Of the 22 patients, 18 were heterozygous for at least 1 of the polymorphisms. In 6 of these patients, LOH had occurred in the tumor DNA. Of 21 patients examined for LOH on chromosome 11q13, only 1, with a corticotroph carcinoma, showed allelic deletion. As controls we studied 28 pituitary tumors of other subtypes (11 clinically nonfunctioning, 8 prolactinomas, and 9 GH-producing adenomas) and found evidence for LOH in only 1 prolactinoma.

In six patients LOH was found at the GR gene locus (chromosome 5) in DNA derived from adenoma cells. Our observations indicate for the first time that LOH at the GR gene locus is a relatively frequent phenomenon in pituitary adenomas of patients with Cushing’s disease. This might explain the relative resistance of the adenoma cells to the inhibitory feedback action of cortisol on ACTH secretion. The specificity of the GR LOH to corticotropinomas supports this concept. Somatic mutations of the GR are not a frequent cause of relative cortisol resistance in these cells.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
T. Tateno, H. Izumiyama, M. Doi, T. Yoshimoto, M. Shichiri, N. Inoshita, K. Oyama, S. Yamada, and Y. Hirata
Differential gene expression in ACTH -secreting and non-functioning pituitary tumors
Eur. J. Endocrinol., December 1, 2007; 157(6): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Nigawara, Y. Iwasaki, M. Asai, M. Yoshida, M. Kambayashi, H. Sashinami, K. Hashimoto, and T. Suda
Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Eliminates Impaired Glucocorticoid Suppression and Induces Apoptosis in Corticotroph Tumor Cells
Endocrinology, February 1, 2006; 147(2): 769 - 772.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Lania, G. Mantovani, and A. Spada
Genetics of Pituitary Tumors: Focus on G-Protein Mutations
Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon
Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo
Cancer Res., April 1, 2000; 60(7): 2056 - 2062.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
P. L. M. Dahia and A. B. Grossman
The Molecular Pathogenesis of Corticotroph Tumors
Endocr. Rev., April 1, 1999; 20(2): 136 - 155.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society